Trial Profile
A Study in Healthy Subjects to Assess the Effect of Intragastric pH and Fasting on the Multiple-Dose Pharmacokinetics of AF-219
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2023
Price :
$35
*
At a glance
- Drugs Gefapixant (Primary) ; Omeprazole
- Indications Asthma; Cough; Interstitial cystitis; Musculoskeletal pain
- Focus Pharmacokinetics
- Sponsors Afferent Pharmaceuticals
- 10 Mar 2015 Status changed from not yet recruiting to completed, according to ClinicalTrials.gov record.
- 05 Sep 2014 New trial record